Proteomic and Phenotypic Studies of Mycoplasma pneumoniae Revealed Macrolide-Resistant Mutation (A2063G) Associated

Zhikun Zhang1,2, Haiwei Dou1, Qing Yuan1

  • 1Beijing Tropical Medicine Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Microbiology Spectrum
|June 28, 2023
PubMed

Insights

Macrolide-resistant Mycoplasma pneumoniae (MP) strains, particularly type I resistant (IR) strains, show altered protein profiles and increased proliferation rates. These changes in protein composition may drive the higher prevalence of IR strains, impacting MP infection treatment and children's health.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Immunology

Background:

  • Macrolide-resistant Mycoplasma pneumoniae (MP) strains, characterized by the A2063G mutation, are increasing.
  • Type I resistant (IR) MP strains are more prevalent than sensitive strains, but the reasons are unclear.
  • Understanding the factors influencing IR strain prevalence is crucial for managing MP infections, especially in children.

Purpose of the Study:

  • To investigate the underlying factors contributing to the altered prevalence of type I resistant (IR) Mycoplasma pneumoniae strains.
  • To analyze proteomic and phenotypic differences between macrolide-resistant and sensitive MP strains.
  • To correlate protein composition changes with MP pathogenicity and transmission potential.

Main Methods:

  • Proteomic analysis to compare protein compositions between different MP genotypes (IS, IIS, IR, IIR).
  • mRNA level detection to assess posttranscriptional regulation of differential proteins.
  • Phenotypic assays to evaluate P1 protein abundance, MP adhesion, proliferation rates, and host cell responses (caspase-3 activity, IL-8 levels).

Main Results:

  • Proteomic analysis revealed significant differences in protein composition, with more differential proteins between IS and IR strains (227) than between IIS and IIR strains (81).
  • Type I resistant (IR) strains exhibited reduced P1 protein abundance and increased proliferation rates, potentially linked to altered glycolysis and one-carbon metabolism.
  • Infection with IR strains showed a trend towards lower caspase-3 activity and higher IL-8 levels in A549 cells, though not statistically significant.

Conclusions:

  • Altered protein composition, particularly reduced P1 abundance and increased proliferation in IR strains, significantly influences MP pathogenicity.
  • These molecular and phenotypic changes in IR strains may contribute to their higher transmission rates and increased prevalence in the population.
  • The findings highlight the need to monitor the prevalence of IR MP strains due to their potential impact on treatment efficacy and public health.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...